Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Ocul Immunol Inflamm ; 31(2): 343-347, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-35113749

RESUMO

PURPOSE: To compare the prostaglandin E2 receptor subtype 3 (EP3) distribution in the lacrimal glands of normals, non-specific dacryoadenitis, and chronic Stevens-Johnson syndrome (SJS) patients. METHODS: Biopsies from lacrimal glands of four chronic SJS patients with severe dry eye disease, four dacryoadenitis patients, and five fresh body donors were assessed for EP3 expression using immunohistochemistry. RESULTS: In normal main and accessory lacrimal glands, EP3 is expressed strongly in nuclei and cytoplasm of majority (>75%) of acini with no ductular expression. In dacryoadenitis, EP3 expression was similar to normal glands. However, lacrimal glands from SJS patients (5-20/HPF mononuclear cells) showed a weak and reduced (<10% acini) EP3 expression within acinar cells. The reduction in intensity was more in glands with higher mononuclear cell infiltration (>10/HPF). CONCLUSION: There is downregulation of EP3 expression in the lacrimal glands of SJS patients, whereas EP3 expression is preserved in non-specific lacrimal gland inflammations.


Assuntos
Dacriocistite , Síndromes do Olho Seco , Aparelho Lacrimal , Síndrome de Stevens-Johnson , Humanos , Aparelho Lacrimal/metabolismo , Receptores de Prostaglandina E Subtipo EP3/metabolismo , Síndrome de Stevens-Johnson/diagnóstico , Síndromes do Olho Seco/metabolismo , Dacriocistite/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA